Patents matching “statin”

US 12290551

Methods for imaging and treatment of somatostatin-receptor positive tumors

Corcept Therapeutics Incorporated · Granted May 6, 2025 · Expires May 1, 2045

US 12258370

Betulastatin compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 25, 2025 · Expires Mar 20, 2045

US 12134610

Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Nov 5, 2024 · Expires Oct 31, 2044

US 12122837

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Oct 22, 2024 · Expires Oct 17, 2044

US 12053511

Cystatin C and Cystatin 9 to treat gut inflammation caused by thermal injury

Boards of Regents, The University of Texas System · Granted Aug 6, 2024 · Expires Aug 1, 2044

US 11957674

Formulations of a somatostatin modulator

CRINETICS PHARMACEUTICALS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

US 11890290

Topical treatment of wounds with statins and cholesterol for scar reduction

Northwestern University · Granted Feb 6, 2024 · Expires Feb 1, 2044

US 11834462

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

US 11827687

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

US 11813314

Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11773076

Crystalline forms of a somatostatin modulator

CRINETICS PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

US 11725043

Ulinastatin polypeptides

DiaMedica USA Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

US 11661441

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Apellis Pharmaceuticals, Inc. · Granted May 30, 2023 · Expires May 25, 2043

US 11629167

Betulastatin compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

US 11608335

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11548889

Emetine auristatin compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11479540

Nonpeptide somatostatin type 5 receptor agonists and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Oct 25, 2022 · Expires Oct 20, 2042

US 11414397

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Aug 16, 2022 · Expires Aug 11, 2042

US 11407789

Cell-penetrating compstatin analogs and uses thereof

Apellis Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

US 11292815

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

Apellis Pharmaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11266641

Formulations of a somatostatin modulator

CRINETICS PHARMACEUTICALS, INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

US 11261230

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

US 11197844

Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

US 11186590

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041